Opus Genetics, Inc. (IRD)
4.62
-0.18
(-3.75%)
USD |
NASDAQ |
May 18, 11:00
Opus Genetics Total Liabilities (Quarterly) : 112.62M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Keros Therapeutics, Inc. | 26.66M |
| Xilio Therapeutics, Inc. | 90.94M |
| ACADIA Pharmaceuticals, Inc. | 357.16M |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
| Amgen, Inc. | 83.31B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 66.79M |
| Shareholders Equity (Quarterly) | -45.84M |
| Debt to Equity Ratio | -0.5658 |
| Current Ratio | 7.131 |
| Net Debt Paydown Yield | -0.44% |